Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET

OBJECTIVE—To investigate prospectively abnormalities of brain glucose utilisation in relation to major or minor neuropsychiatric symptoms in systemic lupus erythematosus (SLE).
METHODS—Positron emission tomography (PET) using F-18-labelled fluorodeoxyglucose was performed in 28 patients with SLE. Pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Weiner, S, Otte, A, Schumacher, M, Klein, R, Gutfleisch, J, Brink, I, Otto, P, Nitzsche, E, Moser, E, Peter, H
Format: Artigo
Idioma:Inglês
Publicat: 2000
Matèries:
Extended Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1753133/
https://ncbi.nlm.nih.gov/pubmed/10784521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.59.5.377
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars